The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy.
about
Management of chronic lymphocytic leukemia (CLL) in the era of B-cell receptor signal transduction inhibitorsRadioimmunotherapy consolidation using 131I-tositumomab for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma in first remission.Determinants of the optimal first-line therapy for follicular lymphoma: a decision analysisFludarabine in Waldenstrom's macroglobulinemia.Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.Unresolved issues in the comparison of therapies and determination of responses in Waldenström macroglobulinemia.Therapy-related myelodysplasia and fludarabine combination therapy - do the benefits justify the risk?The potential combination of BCL-2 inhibitors and ibrutinib as frontline therapy in chronic lymphocytic leukemia.Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.
P2860
Q28081162-4FDF1463-4B42-491F-889A-91749BB129F2Q33424056-2C7C8FF4-7BB0-49AE-978C-4DCFD004562EQ34099792-D7730543-2195-477F-B855-65615A09A92FQ34351916-63980E24-8F2A-40BF-8294-C45C4FDBF670Q42852282-6C62DE28-FC05-48C8-93E0-8CF795E12F77Q42870641-19F68C01-F83A-4EB0-926E-C615F38BF8A8Q42881033-6C94B0A7-D06A-4E72-B0A9-200358D98639Q51014811-8328CF52-4CD2-4F06-A6F6-2AFAC2D9ACA5Q51617424-8A09CC5B-7AB3-4F4F-B347-93BE49148D6F
P2860
The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The frequency, manifestations, ...... bine combination chemotherapy.
@ast
The frequency, manifestations, ...... bine combination chemotherapy.
@en
type
label
The frequency, manifestations, ...... bine combination chemotherapy.
@ast
The frequency, manifestations, ...... bine combination chemotherapy.
@en
prefLabel
The frequency, manifestations, ...... bine combination chemotherapy.
@ast
The frequency, manifestations, ...... bine combination chemotherapy.
@en
P2093
P356
P1433
P1476
The frequency, manifestations, ...... bine combination chemotherapy.
@en
P2093
D Westerman
H Januszewicz
H M Prince
J F Seymour
P304
P356
10.1093/ANNONC/MDP297
P577
2009-07-22T00:00:00Z